AwardedSuppliesEuropeanOpen

TdaP-IPV vaccines

IUC-RIVM · Open · 1 lots · 244442

0 of 6 core insights found

Measures presence, not accuracy · documents remain authoritative

ScopeAdvicePoints of attentionSuitability requirementsAward criteriaTimeline

Type

Supplies

33651600

Estimated value

Not published

To deadline

Ongoing

Knock-outs

n/a

exclusion grounds

Award basis

Best price-quality ratio

Assess manuallyconfidence low

The Rijksinstituut voor Volksgezondheid en Milieu (RIVM) intends to select a supplier through an open procedure to provide the Tetanus-diphtheria-acellular Pertussis – Inactivated Polio Virus (TdaP-IPV) vaccine for the Dutch Immunisation Programme, including the Dutch Caribbean territories. The procurement concerns the supply of an approved, GMP-produced vaccine that complies with EU and WHO standards, featuring CE marking and the required quality documentation. The supplier must offer a reliable supply chain, guarantee timely deliveries, and meet the logistical requirements for both the mainland and the Caribbean region. Pricing must be transparent, with possibilities for volume discounts and a clear payment structure. The RIVM expects a multi-year contract, in which the supplier commits to continuity, traceability, and a rapid response to any potential product issues.

Supplies · Open · European procedure

European

Contracting authority

IUC-RIVM

Contract type

Supplies

Open

Estimated value

Estimate not published

Submission deadline

Ongoing

Scope

European

European procedure

Lots

1 lots

Main CPV code

33651600

Location

Bilthoven

CharacteristicsCPV 33SuppliesEU tenderTdaP-IPVvaccinesRIVM

01What is being requested

The Rijksinstituut voor Volksgezondheid en Milieu (RIVM) intends to select a supplier through an open procedure to provide the Tetanus-diphtheria-acellular Pertussis – Inactivated Polio Virus (TdaP-IPV) vaccine for the Dutch Immunisation Programme, including the Dutch Caribbean territories. The procurement concerns the supply of an approved, GMP-produced vaccine that complies with EU and WHO standards, featuring CE marking and the required quality documentation. The supplier must offer a reliable supply chain, guarantee timely deliveries, and meet the logistical requirements for both the mainland and the Caribbean region. Pricing must be transparent, with possibilities for volume discounts and a clear payment structure. The RIVM expects a multi-year contract, in which the supplier commits to continuity, traceability, and a rapid response to any potential product issues.

The objective of this ITT is to fulfil the need for Tetanus diphtheria acellular Pertussis – Inactivated Polio Virus (TdaP-IPV) vaccine for the Dutch Immunisation Programme (including the Dutch Caribbean).

33651600Supplies

1Lot 1€1

02Outcome

Awarded

GlaxoSmithKline B.V.

03Exclusion grounds

Exclusion grounds — consult the ESPD

No specific exclusion grounds were extracted. In a European tender, the mandatory and discretionary grounds of art. 2.86/2.87 of the Dutch Procurement Act almost always apply — check the European Single Procurement Document (ESPD).

04Value in context

Estimate not published

The contracting authority did not publish an estimated value — common for a large share of contracts. The EU threshold for leveringen is € 221.000, for reference.

05Bidders in this segment

#Likely bidderFitWins

1GlaxoSmithKline B.V.SME786×

2Johnson & Johnson Medical B.V.SME7716×

3Mediost B.V.SME7614×

4King Nederland B.V.SME7210×

5Fuego Tiel B.V.SME729×

6Skills Meducation B.V.SME7110×

06Tender documents

TN337303 - SF03 Aankondiging van een gegunde opdracht 20220212085429pdfFeb 12, 2022 · 23 KB

TN337303 - SF02 Aankondiging van een opdracht 20211120123317pdfNov 20, 2021 · 27 KB

07Legal themes that may be relevant here

Advies 121> Nationale openbare aanbestedingsprocedure. Kan van inschrijvers gevraagd worden een opgave te doen van onvoorziene gebeurtenisse Advies 59> Meervoudig onderhandse aanbestedingsprocedure met betrekking tot een opdracht voor de levering van postdiensten en bezorging. In Advies 53> Europese openbare procedure voor een overheidsopdracht tot het verrichten van diensten bestaande uit (dagelijks en periodiek) sc Advies 681> Aanbesteder heeft een opdracht met een geraamde waarde boven de Europese drempelwaarde geheim verklaard en onderhands gegund aanComplaint upheld Advies 48> Europese niet-openbare procedure voor werktuigkundige en elektrotechnische installaties van de nieuwbouw van een multifunctionel

08Frequently asked questions

What is the objective of this assignment?

The assignment is intended for the supply of the Tetanus-diphtheria-acellular Pertussis – Inactivated Polio Virus (TdaP-IPV) vaccine for the Dutch Immunisation Programme, including the Dutch Caribbean territories.

Which requirements must the supplied vaccine meet?

It concerns the supply of an approved, GMP-produced vaccine that complies with EU and WHO standards and must be provided with CE marking and the required quality documentation.

What are the expectations regarding delivery and the supply chain?

The supplier must offer a reliable supply chain, guarantee timely deliveries, and meet the logistical requirements for both the mainland and the Caribbean region.

What contractual aspects are expected from the supplier?

A multi-year contract is expected, in which the supplier commits to continuity, traceability, and a rapid response to any potential product issues.

Automatically compiled from the official tender data and documents.

09Estimated value versus the market

p25
€ 317K

median
€ 892K

p75
€ 3,3 mln

deze opdracht

Gegunde waarden in CPV 33 · leveringen n=528